Larimar Therapeutics, Inc.·4

May 18, 2:12 PM ET

Truitt Joseph 4

4 · Larimar Therapeutics, Inc. · Filed May 18, 2023

Insider Transaction Report

Form 4
Period: 2023-05-17
Transactions
  • Purchase

    Common Stock

    2023-05-17$3.73/sh+2,750$10,2582,750 total

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES